Dr Rhys Thomas
| Addressing ethnic disparities in neurological research in the United Kingdom: An example from the prospective multicentre COVID-19 Clinical Neuroscience Study | 2024 |
|
Kathryn Bush
Dr Emer Cullen
Dr Susanna Mills
Dr Rhys Thomas
Dr Andrew Kingston
et al. | Assessing the extent and determinants of socioeconomic inequalities in epilepsy in the UK: a systematic review and meta-analysis of evidence | 2024 |
|
Sarah Gascoigne
Nathan Evans
Dr Gerard Hall
Csaba Kozma
Dr Mariella Panagiotopoulou
et al. | Incomplete resection of the intracranial electroencephalographic seizure onset zone is not associated with postsurgical outcomes | 2024 |
|
Dr Rhys Thomas
| Practical approach to anti seizure medications, an update | 2024 |
|
Dr David Lewis-Smith
Dr Rhys Thomas
| The Human Phenotype Ontology in 2024: phenotypes around the world | 2024 |
|
Dr Rhys Thomas
| The promise of AI Large Language Models for Epilepsy care | 2024 |
|
Dr Rhys Thomas
| The role of copy number variants in the genetic architecture of common familial epilepsies | 2024 |
|
Dr Rhys Thomas
| Therapeutic strategies during cenobamate treatment initiation: Delphi panel recommendations | 2024 |
|
Dr Rhys Thomas
| Utilising accessible and reproducible neurological assessments in clinical studies: Insights from use of the Neurological Impairment Scale in the multi-centre COVID-CNS study | 2024 |
|
Harry Clifford
Professor Yujiang Wang
Dr Rhys Thomas
Dr Tiago da Silva Costa
Professor Peter Taylor
et al. | Vagus nerve stimulation for epilepsy: A narrative review of factors predictive of response | 2024 |
|
Dr Rhys Thomas
| What the Top Ten epilepsy research priorities mean for the UK research ecosystem | 2024 |
|
Sarah Gascoigne
Dr Gabrielle Schroeder
Dr Mariella Panagiotopoulou
Dr Jessica Blickwedel
Christoforos Papasavvas
et al. | A library of quantitative markers of seizure severity | 2023 |
|
Dr Faye McLeod
Anna Dimtsi
Amy Marshall
Dr David Lewis-Smith
Dr Rhys Thomas
et al. | Altered synaptic connectivity in an in vitro human model of STXBP1 encephalopathy | 2023 |
|
Kathryn Bush
Dr Emer Cullen
Dr Rhys Thomas
Professor Sheena Ramsay
| Assessing the extent and distribution of socioeconomic inequalities in Epilepsy, in the United Kingdom; a systematic evidence review. | 2023 |
|
Professor John Simpson
Dr Jo Elverson
Dr Vicky Ewan
Dr Hilary Tedd
Dr Rhys Thomas
et al. | BTS clinical statement on aspiration pneumonia | 2023 |
|
Jonathan Horsley
Dr Rhys Thomas
Professor Yujiang Wang
Professor Peter Taylor
| Complementary structural and functional abnormalities to localise epileptogenic tissue | 2023 |
|
Dr Rhys Thomas
| Cost-effectiveness of cenobamate for focal seizures in people with drug-resistant epilepsy | 2023 |
|
Dr David Lewis-Smith
Dr Rhys Thomas
| Genome-wide identification and phenotypic characterization of seizure-associated copy number variations in 741,075 individuals | 2023 |
|
Dr Rhys Thomas
| GWAS meta-analysis of over 29,000 people with epilepsy identifies 26 risk loci and subtype-specific genetic architecture | 2023 |
|
Dr Rhys Thomas
| Rapid switching from levetiracetam to brivaracetam in pharmaco-resistant epilepsy in people with and without intellectual disabilities: a naturalistic case control study | 2023 |
|
Dr Rhys Thomas
| SLCO5A1 and synaptic assembly genes contribute to impulsivity in juvenile myoclonic epilepsy | 2023 |
|
Dr Rhys Thomas
| Variation in prognosis and treatment outcome in juvenile myoclonic epilepsy: a Biology of Juvenile Myoclonic Epilepsy Consortium proposal for a practical definition and stratified medicine classifications | 2023 |
|
Dr Rhys Thomas
Dr David Lewis-Smith
| A review of the clinical spectrum of BRAT1 disorders with addition of a developmental and epileptic encephalopathy with survival to adulthood | 2022 |
|
Dr Rhys Thomas
| A systems-level analysis highlights microglial activation as a modifying factor in common epilepsies | 2022 |
|
Dr Rhys Thomas
| Acute seizure risk in patients with encephalitis: development and validation of clinical prediction models from two independent prospective multicentre cohorts | 2022 |
|
Dr Rhys Thomas
| Association of ultra-rare coding variants with genetic generalized epilepsy: A case–control whole exome sequencing study | 2022 |
|
Dr David Lewis-Smith
Dr Stephan Jaiser
Dr Rhys Thomas
| Autoimmune musicogenic bilateral temporal lobe epilepsy | 2022 |
|
Dr David Lewis-Smith
Dr Rhys Thomas
| Computational analysis of neurodevelopmental phenotypes: Harmonization empowers clinical discovery | 2022 |
|
Dr Rhys Thomas
| Correction: Increased volume of cerebral oedema is associated with risk of acute seizure activity and adverse neurological outcomes in encephalitis – regional and volumetric analysis in a multi-centre cohort | 2022 |
|
Dr Chiara Pizzamiglio
Dr Rhys Thomas
Professor Grainne Gorman
Professor Bobby McFarland
Professor Michael Hanna
et al. | COVID-19-Related Outcomes in Primary Mitochondrial Diseases: An International Study | 2022 |
|
Dr Mariella Panagiotopoulou
Christoforos Papasavvas
Dr Gabrielle Schroeder
Dr Rhys Thomas
Professor Peter Taylor
et al. | Fluctuations in EEG band power at subject-specific timescales over minutes to days explain changes in seizure evolutions | 2022 |
|
Dr Yi Ng
Dr Nichola Lax
Dr Alasdair Blain
Dr Daniel Erskine
Professor Mark Baker
et al. | Forecasting stroke-like episodes and outcomes in mitochondrial disease | 2022 |
|
Dr Rhys Thomas
| Increased volume of cerebral oedema is associated with risk of acute seizure activity and adverse neurological outcomes in encephalitis – regional and volumetric analysis in a multi-centre cohort | 2022 |
|
Dr David Lewis-Smith
Amy Winder
Professor Mark Baker
Dr Rhys Thomas
| Late-onset cluster seizures and intellectual disability associated with a novel truncation variant in SMC1A | 2022 |
|
Dr Anna Basu
Dr David Lewis-Smith
Dr Rhys Thomas
| Natural History Study of STXBP1-Developmental and Epileptic Encephalopathy Into Adulthood | 2022 |
|
Dr Rhys Thomas
Catherine Feeney
| Research priorities for mitochondrial disorders: Current landscape and patient and professional views | 2022 |
|
Dr Rhys Thomas
| Sex-specific disease modifiers in juvenile myoclonic epilepsy | 2022 |
|
Dr Rhys Thomas
| Structural network alterations in focal and generalized epilepsy assessed in a worldwide ENIGMA study follow axes of epilepsy risk gene expression | 2022 |
|
Dr Rhys Thomas
| The different clinical facets of SYN1-related neurodevelopmental disorders | 2022 |
|
Professor Peter Taylor
Dr Rhys Thomas
| The ENIGMA-Epilepsy working group: Mapping disease from large data sets | 2022 |
|
Dr Alice Willison
Dr Rhys Thomas
| The neurodevelopmental spectrum seen with CHD2 variants | 2022 |
|
Jonathan Horsley
Dr Gabrielle Schroeder
Dr Rhys Thomas
Professor Yujiang Wang
Professor Peter Taylor
et al. | Volumetric and structural connectivity abnormalities co-localise in TLE | 2022 |
|
Professor Peter Taylor
Dr Rhys Thomas
| Artificial intelligence for classification of temporal lobe epilepsy with ROI-level MRI data: A worldwide ENIGMA-Epilepsy study | 2021 |
|
Dr Rhys Thomas
| Cerebral venous thrombosis after vaccination against COVID-19 in the UK: a multicentre cohort study | 2021 |
|
Dr David Lewis-Smith
Dr Rhys Thomas
Dr Horn Lai
| Clinical and Genetic Features in Patients With Reflex Bathing Epilepsy | 2021 |
|
Dr David Lewis-Smith
Dr Rhys Thomas
Dr Horn Lai
| Clinical and genetic features in patients with reflex bathing epilepsy | 2021 |
|
Dr Rhys Thomas
| Clinicians embracing social media: Potential and pitfalls | 2021 |
|
Dr Rhys Thomas
| Considerations for causality assessment of neurological and neuropsychiatric complications of SARS-CoV-2 vaccines: from cerebral venous sinus thrombosis to functional neurological disorder | 2021 |
|
Dr Rhys Thomas
| COVID-19 and psychosis risk: Real or delusional concern? | 2021 |
|
Dr Rhys Thomas
| COVID-19 Encephalitis with SARS-CoV-2 Detected in Cerebrospinal Fluid Presenting as a Stroke Mimic | 2021 |
|
Dr Rhys Thomas
| Expert opinion: use of valproate in girls and women of childbearing potential with epilepsy: recommendations and alternatives based on a review of the literature and clinical experience—a European perspective | 2021 |
|
Dr Rhys Thomas
| Invitation to participate in a prospective case–control study of sudden unexpected death in epilepsy | 2021 |
|
Dr Rhys Thomas
| Leukoencephalopathy with calcifications and cysts: Genetic and phenotypic spectrum | 2021 |
|
Dr David Lewis-Smith
Dr Rhys Thomas
| Modeling seizures in the Human Phenotype Ontology according to contemporary ILAE concepts makes big phenotypic data tractable | 2021 |
|
Dr Rhys Thomas
| Neurological and Psychiatric Manifestations of COVID-19 in UK Children: A Prospective National Cohort Study | 2021 |
|
Dr Naomi Thomas
Professor Mark Baker
Dr Rhys Thomas
Dr Michael Griffiths
| Neurological manifestations of SARS-CoV-2 infection in hospitalised children and adolescents in the UK: a prospective national cohort study | 2021 |
|
Dr Rhys Thomas
| Paediatric sudden unexpected death in epilepsy: A parental report cohort | 2021 |
|
Dr Naomi Thomas
Dr Rhys Thomas
| Spectrum, Risk Factors, and Outcomes of Neurological and Psychiatric Complications of COVID-19: A UK-Wide Cross-Sectional Surveillance Study | 2021 |
|
Dr Rhys Thomas
| Topographic divergence of atypical cortical asymmetry and atrophy patterns in temporal lobe epilepsy | 2021 |
|
Dr Rhys Thomas
| Trait impulsivity in Juvenile Myoclonic Epilepsy | 2021 |
|
Dr Rhys Thomas
| Trait impulsivity in Juvenile Myoclonic Epilepsy | 2021 |
|
Dr David Lewis-Smith
Dr Rhys Thomas
| Ultra-rare Genetic Variants Influence Clinical Features of the Epilepsies. | 2021 |
|
Dr Rhys Thomas
| A tiered strategy for investigating status epilepticus | 2020 |
|
Dr Rhys Thomas
| Characterising neuropsychiatric disorders in patients with COVID-19 – Authors' reply | 2020 |
|
Professor Mark Baker
Dr Rhys Thomas
| Clinical Reasoning: A 25-year old woman with recurrent episodes of collapse and loss of consciousness | 2020 |
|
Dr Rhys Thomas
| Defining causality in COVID-19 and neurological disorders | 2020 |
|
Dr David Lewis-Smith
Dr Rhys Thomas
| Early-onset genetic epilepsies reaching adult clinics | 2020 |
|
Dr Rhys Thomas
| Epilepsy, an orphan disorder within the neurodevelopmental family | 2020 |
|
Dr Rhys Thomas
| Generalized, focal, and combined epilepsies in families: New evidence for distinct genetic factors | 2020 |
|
Dr David Lewis-Smith
Dr Naomi Thomas
Dr Rhys Thomas
| Molecular genetic management of epilepsy | 2020 |
|
Dr Rhys Thomas
| Network-based atrophy modeling in the common epilepsies: A worldwide ENIGMA study | 2020 |
|
Dr Naomi Thomas
Dr Rhys Thomas
Professor Mark Baker
Dr Alan Gemski
Dr Hisham Hamdalla
et al. | Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study | 2020 |
|
Dr Rhys Thomas
| Response to letter to editor: “Knowing when and how to use epilepsy screening questionnaires” | 2020 |
|
Dr Rhys Thomas
| Self-driving cars: a qualitative study into the opportunities, challenges and perceived acceptability for people with epilepsy | 2020 |
|
Dr David Lewis-Smith
Dr Rhys Thomas
| Semantic similarity analysis reveals robust gene-disease relationships in developmental and epileptic encephalopathies | 2020 |
|
Dr Rhys Thomas
| The "maternal effect" on epilepsy risk: analysis of familial epilepsies and reassessment of prior evidence | 2020 |
|
Dr Rhys Thomas
| The evidence for switching dibenzazepines in people with epilepsy | 2020 |
|
Dr Albert Lim
Dr Rhys Thomas
| The mitochondrial epilepsies | 2020 |
|
Dr David Lewis-Smith
Dr Rhys Thomas
| The prevalence of genetically diagnosable epilepsies in young adulthood: How many should we be looking for? | 2020 |
|
Dr Rhys Thomas
| The view of the clinician and the scientist on the family experience of sudden epilepsy deaths | 2020 |
|
Professor Peter Taylor
Dr Rhys Thomas
| White matter abnormalities across different epilepsy syndromes in adults: an ENIGMA-Epilepsy study | 2020 |
|
Dr Marta Bertoli
Dr Simon Zwolinski
Dr Rhys Thomas
| Widening of the genetic and clinical spectrum of Lamb–Shaffer syndrome, a neurodevelopmental disorder due to SOX5 haploinsufficiency | 2020 |
|
Dr Rhys Thomas
| Clinical spectrum of STX1B-related epileptic disorders. | 2019 |
|
Dr Rhys Thomas
| Epilepsy and seizures in young people with 22q11.2 deletion syndrome: prevalence and links with other neurodevelopmental disorders | 2019 |
|
Dr Rhys Thomas
| Epilepsy in families: Age at onset is a familial trait, independent of syndrome | 2019 |
|
Dr Rhys Thomas
Dr Naomi Thomas
| Genetic chameleons: Remember the relapsing disorders | 2019 |
|
Dr Rhys Thomas
| Hereditary Hyperekplexia Overview | 2019 |
|
Dr Rhys Thomas
| Intestinal-Cell Kinase and Juvenile Myoclonic Epilepsy | 2019 |
|
Dr Rhys Thomas
| Learnings from deaths – the Epilepsy Deaths Register | 2019 |
|
Dr Meher Lad
Dr Rhys Thomas
Dr Kirstie Anderson
Professor Tim Griffiths
| Niemann-Pick type C: Contemporary diagnosis and treatment of a classical disorder | 2019 |
|
Dr Rhys Thomas
| Quantitative analysis of phenotypic elements augments traditional electroclinical classification of common familial epilepsies | 2019 |
|
Dr David Lewis-Smith
Dr Rhys Thomas
| The adult phenotypes of paediatric-onset genetic epilepsies | 2019 |
|
Alex Hagan
Dr David Lewis-Smith
Dr Rhys Thomas
| Analysis of pedigree structure on epilepsy families: a global review | 2018 |
|
Dr Rhys Thomas
Mark Cunningham
| Cannabis and epilepsy | 2018 |
|
Dr Rhys Thomas
| Complement system biomarkers in epilepsy | 2018 |
|
Dr Rhys Thomas
| Educational Attainment of Children Born to Mothers with Epilepsy | 2018 |
|
Dr Rhys Thomas
| Neurologic phenotypes associated with COL4A1/2 mutations: Expanding the spectrum of disease. | 2018 |
|
Dr Rhys Thomas
| Structural brain abnormalities in the common epilepsies assessed in a worldwide ENIGMA study | 2018 |
|
Dr Rhys Thomas
| Valproate: life-saving, life-changing | 2018 |
|
Dr Rhys Thomas
| Valproate: Life-saving, life-changing | 2018 |
|
Dr Rhys Thomas
| Epilepsy treatment priorities: answering the questions that matter | 2017 |
|
Dr Rhys Thomas
| Gamification of Medication Adherence in Epilepsy | 2017 |
|
Dr Rhys Thomas
| High Rate of Recurrent De Novo Mutations in Developmental and Epileptic Encephalopathies | 2017 |
|
Dr Rhys Thomas
| New SMARCA2 Mutation in a Patient with Nicolaides–Baraitser Syndrome and Myoclonic Astatic Epilepsy | 2017 |
|
Dr Rhys Thomas
| On the road again: assessing driving ability in patients with neurological conditions | 2017 |
|
Dr Douglas Crompton
Dr Rhys Thomas
| Phenotypic analysis of 303 multiplex families with common epilepsies | 2017 |
|
Dr Rhys Thomas
| Sudden death in epilepsy: Insights from the last 25 years | 2017 |
|
Dr Rhys Thomas
| Ultra-rare genetic variation in common epilepsies: a case-control sequencing study | 2017 |
|
Dr Rhys Thomas
| Cluster of atypical adult Guillain-Barré syndrome temporally associated with neurological illness due to EV-D68 in children, South Wales, United Kingdom, October 2015 to January 2016 | 2016 |
|
Dr Rhys Thomas
| Cognitive Performance Among Carriers of Pathogenic Copy Number Variants: Analysis of 152,000 UK Biobank Subjects | 2016 |
|
Dr Rhys Thomas
| Editorial: The future of medicine will be dark without international collaboration | 2016 |
|
Dr Rhys Thomas
| Generalized Epilepsy and Myoclonic Seizures in 22q11.2 Deletion Syndrome | 2016 |
|
Dr Rhys Thomas
| Pathogenic copy number variants and SCN1A mutations in patients with intellectual disability and childhood-onset epilepsy | 2016 |
|
Dr Rhys Thomas
| The consequences of valproate exposure in utero | 2016 |
|
Dr Rhys Thomas
| What can rare variant genetics tell us about cognition and intellectual difficulties? | 2016 |
|
Dr Rhys Thomas
| CHD2 myoclonic encephalopathy is frequently associated with self-induced seizures | 2015 |
|
Dr Rhys Thomas
| Epilepsy and bipolar disorder | 2015 |
|
Dr Rhys Thomas
| Epilepsy and deprivation, a data linkage study | 2015 |
|
Dr Rhys Thomas
| Ethnicity can predict GLRA1 genotypes in hyperekplexia | 2015 |
|
Dr Rhys Thomas
| Etiology of epilepsy | 2015 |
|
Dr Rhys Thomas
| Genome-wide Polygenic Burden of Rare Deleterious Variants in Sudden Unexpected Death in Epilepsy | 2015 |
|
Dr Rhys Thomas
| Hyperconnectivity in juvenile myoclonic epilepsy: A network analysis | 2015 |
|
Dr Rhys Thomas
| Hyperekplexia: overexcitable and underdiagnosed | 2015 |
|
Dr Rhys Thomas
| Testing new treatments for paediatric epilepsies | 2015 |
|
Dr Rhys Thomas
| A comprehensive neuropsychological description of cognition in drug-refractory juvenile myoclonic epilepsy | 2014 |
|
Dr Rhys Thomas
| A Novel GABRG2 mutation, p.R1367*, in a family with GEFS+ and extended phenotypes | 2014 |
|
Dr Rhys Thomas
| Concepts and controversies of juvenile myoclonic epilepsy: still an enigmatic epilepsy | 2014 |
|
Dr Rhys Thomas
| Epilepsy prevalence and socioeconomic deprivation in England | 2014 |
|
Dr Rhys Thomas
| Executive functions and psychiatric symptoms in drug-refractory juvenile myoclonic epilepsy | 2014 |
|
Dr Rhys Thomas
| Novel auto-antibody syndromes | 2014 |
|
Dr Rhys Thomas
| The hidden genetics of epilepsy - a clinically important new paradigm | 2014 |
|
Dr Rhys Thomas
| Trends in the first antiepileptic drug prescribed for epilepsy between 2000 and 2010 | 2014 |
|
